| For: | Mahmoudvand S, Shokri S, Taherkhani R, Farshadpour F. Hepatitis C virus core protein modulates several signaling pathways involved in hepatocellular carcinoma. World J Gastroenterol 2019; 25(1): 42-58 [PMID: 30643357 DOI: 10.3748/wjg.v25.i1.42] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v25/i1/42.htm |
| Number | Citing Articles |
| 1 |
Kevin Dzobo. The Role of Viruses in Carcinogenesis and Molecular Targeting: From Infection to Being a Component of the Tumor Microenvironment. OMICS: A Journal of Integrative Biology 2021; 25(6) doi: 10.1089/omi.2021.0052
|
| 2 |
Saba Zafar, Farhat Jabeen, Aiman Sajjad. The Microbiome and Cancer. 2024; doi: 10.1007/978-981-97-6948-3_5
|
| 3 |
Thomas Sorrell, Ethan Ou, Fenyong Liu. Targeting Cancer-Associated Transcripts with Engineered RNase P Ribozymes. SynBio 2025; 3(4) doi: 10.3390/synbio3040020
|
| 4 |
Judyta Górka, Katarzyna Miękus. Molecular landscape of clear cell renal cell carcinoma: targeting the Wnt/β-catenin signaling pathway. Discover Oncology 2025; 16(1) doi: 10.1007/s12672-025-02228-5
|
| 5 |
Hyunyoung Yoon, Ji-Min Park, Jiwoo Han, Yerin Kwon, Kyung Lib Jang. Hepatitis C Virus Core Induces p53 Ser-15 Phosphorylation to Facilitate E6-Associated Protein-Mediated Proteasomal Degradation of p53. Cells 2026; 15(5) doi: 10.3390/cells15050415
|
| 6 |
Yasutoshi Nozaki, Hayato Hikita, Satoshi Tanaka, Kenji Fukumoto, Makiko Urabe, Katsuhiko Sato, Yuta Myojin, Akira Doi, Kazuhiro Murai, Sadatsugu Sakane, Yoshinobu Saito, Takahiro Kodama, Ryotaro Sakamori, Tomohide Tatsumi, Tetsuo Takehara. Persistent hepatocyte apoptosis promotes tumorigenesis from diethylnitrosamine-transformed hepatocytes through increased oxidative stress, independent of compensatory liver regeneration. Scientific Reports 2021; 11(1) doi: 10.1038/s41598-021-83082-7
|
| 7 |
Noé Velázquez-Márquez, Laura Cristina Huelgas-Saavedra. Pathogens Associated with the Development of Cancer in Humans. 2024; doi: 10.1007/978-3-031-62558-9_1
|
| 8 |
. 2022; doi: 10.70675/5459cc38zba09z4453z8fbczd8bbb9f7d05a
|
| 9 |
Hyunyoung Yoon, Kyung Lib Jang. Hydrogen Peroxide Inhibits Hepatitis C Virus Replication by Downregulating Hepatitis C Virus Core Levels through E6-Associated Protein-Mediated Proteasomal Degradation. Cells 2023; 13(1) doi: 10.3390/cells13010062
|
| 10 |
. 2021; doi: 10.70675/ccbe884cze6eez4f76z9b51z0462f971288f
|
| 11 |
Dong-Xu Liao, Xiang An, Gui-Xiang Huang, Tong-Ling Yuan. The impact of metabolic reprogramming in hepatocellular carcinoma on T cell. Frontiers in Immunology 2025; 16 doi: 10.3389/fimmu.2025.1696113
|
| 12 |
Shahab Mahmoudvand, Somayeh Shokri. Interactions between SARS coronavirus 2 papain‐like protease and immune system: A potential drug target for the treatment of COVID‐19. Scandinavian Journal of Immunology 2021; 94(4) doi: 10.1111/sji.13044
|
| 13 |
Maria R. Emma, Giuseppa Augello, Antonella Cusimano, Antonina Azzolina, Giuseppe Montalto, James A. McCubrey, Melchiorre Cervello. GSK-3 in liver diseases: Friend or foe?. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research 2020; 1867(9) doi: 10.1016/j.bbamcr.2020.118743
|
| 14 |
|
| 15 |
Dina Mofed, Salwa Sabet, Ahmed A. Baiomy, Tamer Z. Salem. The Transgene Expression of the Immature Form of the HCV Core Protein (C191) and the LncRNA MEG3 Increases Apoptosis in HepG2 Cells. Current Issues in Molecular Biology 2022; 44(8) doi: 10.3390/cimb44080249
|
| 16 |
Iman H. Ibrahim, Ola Sayed M. Ali, Adel A. El-Sahar, Mohamed Elrefaei, Nabila El-Sheikh. Telomerase Expression Related with Poor Immune Response to HCV Core Antigen in Egyptian HCV Patients’ PBMCs. Journal of Clinical and Experimental Hepatology 2023; 13(6) doi: 10.1016/j.jceh.2023.06.004
|
| 17 |
Hemalatha Mani, Jui-Hung Yen, Hao-Jen Hsu, Chun-Chun Chang, Je-Wen Liou. Hepatitis C virus core protein. Tzu Chi Medical Journal 2022; 34(2) doi: 10.4103/tcmj.tcmj_97_21
|
| 18 |
Ruimin Liu, Yan Sun, Shuai Chen, Yun Hong, Zhongxian Lu. FOXD3 and GAB2 as a pair of rivals antagonistically control hepatocellular carcinogenesis. The FEBS Journal 2022; 289(15) doi: 10.1111/febs.16403
|
| 19 |
Rahul Kumar Vempati, Rama Rao Malla. Theranostics and Precision Medicine for the Management of Hepatocellular Carcinoma, Volume 3. 2022; doi: 10.1016/B978-0-323-99283-1.00012-4
|
| 20 |
Necla Kulabaş, Jin-Ching Lee, Özlem Bingöl Özakpınar, İlkay Küçükgüzel. Synthesis and anti-HCV activity of novel 5-arylmethylene-1,3-thiazolidin-4-one derivatives via suppression of NS5B polymerase and COX-2. Journal of Molecular Structure 2024; 1311 doi: 10.1016/j.molstruc.2024.138407
|
| 21 |
Ningzi Zang, Yingxu Wu, Pin Li, Yongming Liu, Shiwen Wang, Jiapeng Leng, Libin Zhan, Xiaodong Lyu, Lijian Pang, Jiaran Wang. Viral Pathogens and Pulmonary Fibrosis: EMT‐Driven Mechanisms and Insights From Traditional Chinese Medicine. Reviews in Medical Virology 2026; 36(2) doi: 10.1002/rmv.70118
|
| 22 |
Pankaj Trivedi, Sandesh Kumar Patel, Diana Bellavia, Elena Messina, Rocco Palermo, Simona Ceccarelli, Cinzia Marchese, Eleni Anastasiadou, Lisa M. Minter, Maria Pia Felli. When Viruses Cross Developmental Pathways. Frontiers in Cell and Developmental Biology 2021; 9 doi: 10.3389/fcell.2021.691644
|
| 23 |
Shaian Tavakolian, Seidamir Pasha Tabaeian, Abolfazl Namazi, Ebrahim Faghihloo, Abolfazl Akbari. Role of the VEGF in virus‐associated cancers. Reviews in Medical Virology 2024; 34(1) doi: 10.1002/rmv.2493
|
| 24 |
Igor P. Bobrov, Alexander F. Lazarev, Nikolay A. Korsikov, Andrey Yu. Dolgatov, Alexander V. Lepilov, Elena S. Dolgatova, Anna A. Pimenova, Elena L. Lushnikova, Maxim A. Bakarev. Nucleolus, ribosome biogenesis, and tumor growth: a review. Russian Journal of Oncology 2025; 30(4) doi: 10.17816/onco665787
|
| 25 |
Francisca Sosa-Jurado, Joselyn Serrano-Casas, Luis Márquez-Domínguez, Nora H. Rosas-Murrieta, Miguel A. Mendoza-Torres, Álvaro Montiel-Jarquín, Olga L. Mercado-García, Ricardo A. Cruz-Cervantes, Montserrat Reyes-Mendoza, Gerardo Santos-López. Prevalence and Clinical Significance of the Hepatitis C Virus Core Protein 70Q/H Mutation and Its Association With Hepatocellular Carcinoma-Related Markers in Mexican Patients. Journal of Clinical and Experimental Hepatology 2026; 16(6) doi: 10.1016/j.jceh.2026.103643
|
| 26 |
Hasini Chintapudi, Kovuru Gopalaiah, Vaishnavi Kuppala, Ganji Purnachandra Nagaraju, Bassel F. El-Rayes. Targeting DNA Repair Mechanisms, Tumor Genetics, and Signaling Pathways. 2026; doi: 10.1016/B978-0-443-43976-6.00003-X
|
| 27 |
Fatemeh Farshadpour, Reza Taherkhani, Farkhondeh Bakhtiari, Haruki Komatsu. Prevalence and Predominant Genotype of Hepatitis C Virus Infection and Associated Risk Factors among Pregnant Women in Iran. BioMed Research International 2021; 2021(1) doi: 10.1155/2021/9294276
|
| 28 |
. 2021; doi: 10.70675/7b90b011z4b49z476fzaddez3ca2884bf127
|
| 29 |
Chia-Chi Wang, Kuo-Chih Tseng, I-Shiang Tzeng, Jia-Horng Kao. The impact of cytokine change after hepatitis C virus clearance by direct antiviral agents on the risk of hepatocellular carcinoma. Journal of the Formosan Medical Association 2021; 120(3) doi: 10.1016/j.jfma.2020.10.015
|
| 30 |
Jinyi Li, Yuanda Liu. Regulation of immune tolerance in hepatocellular carcinoma by liver diseases: a review. Infectious Agents and Cancer 2026; 21(1) doi: 10.1186/s13027-026-00764-5
|
| 31 |
Habibollah Mirzaei, Saeed Ghorbani, Sayyad Khanizadeh, Haideh Namdari, Ebrahim Faghihloo, Abolfazl Akbari. Histone deacetylases in virus‐associated cancers. Reviews in Medical Virology 2020; 30(1) doi: 10.1002/rmv.2085
|
| 32 |
Leonardo Stella, Francesco Santopaolo, Antonio Gasbarrini, Maurizio Pompili, Francesca Romana Ponziani. Viral hepatitis and hepatocellular carcinoma: From molecular pathways to the role of clinical surveillance and antiviral treatment. World Journal of Gastroenterology 2022; 28(21): 2251-2281 doi: 10.3748/wjg.v28.i21.2251
|
| 33 |
Anum Syyam, Hira Raheem Akbar, Zuzana Macek Jilkova, Samia Afzal. Role of Genetic and Epigenetic Modifications in the Progression of Hepatocellular Carcinoma in Chronic HCV Patients. Livers 2023; 3(1) doi: 10.3390/livers3010008
|
| 34 |
Khumbuzile Canham, Pragalathan Naidoo, Sibusiso Senzani, Sayed Shakeel Kader, Zilungile L. Mkhize-Kwitshana. HIV, Viral Hepatitis, and Schistosomiasis Association with Liver Cancer: A Systematic Review. Microorganisms 2025; 13(12) doi: 10.3390/microorganisms13122753
|
| 35 |
Lap P. Nguyen, Tram T. T. Nguyen, Huu C. Nguyen, Hang T. Pham, Kang Min Han, Dong Hwa Choi, Eun-Mee Park, Sang Min Kang, Dongseob Tark, Yun-Sook Lim, Soon B. Hwang, J.-H. James Ou. Cortactin Interacts with Hepatitis C Virus Core and NS5A Proteins: Implications for Virion Assembly. Journal of Virology 2020; 94(19) doi: 10.1128/JVI.01306-20
|
| 36 |
James Palmer, Shahrzad Javadi, Stella Yao, Shymaa E. Bilasy, Ahmed El-Shamy. Direct-Acting Antivirals against Hepatitis C. 2026; doi: 10.1016/B978-0-443-41363-6.00011-1
|
| 37 |
Beatriz Torres-Vázquez, Ana María de Lucas, Carlos García-Crespo, Juan Antonio García-Martín, Adrián Fragoso, María Fernández-Algar, Celia Perales, Esteban Domingo, Miguel Moreno, Carlos Briones. In vitro Selection of High Affinity DNA and RNA Aptamers that Detect Hepatitis C Virus Core Protein of Genotypes 1 to 4 and Inhibit Virus Production in Cell Culture. Journal of Molecular Biology 2022; 434(7) doi: 10.1016/j.jmb.2022.167501
|
| 38 |
Tadej Strojnik. Advanced Concepts and Strategies in Central Nervous System Tumors. Oncology 2024; 2 doi: 10.5772/intechopen.1006516
|
| 39 |
Jing Yuan, Jian He, Wei Liu, Yang Luo, Yanping Li, Xianxi Zheng, Deming Deng, Fengliang Tian, Dan Nie, Peter Pelka. Hepatitis C virus core promotes hepatic cancer stem cell formation via β-catenin-mediated EpCAM upregulation. Microbiology Spectrum 2026; 14(5) doi: 10.1128/spectrum.02859-25
|
| 40 |
H.H. Rashwan, A.M. Taher, H.A. Hassan, A.A. Awaji, C.J. Kiriacos, R.A. Assal, R.A. Youness. Harnessing the supremacy of MEG3 LncRNA to defeat gastrointestinal malignancies. Pathology - Research and Practice 2024; 256 doi: 10.1016/j.prp.2024.155223
|
| 41 |
Lihua Qi, Bai Hu, Canhui Cao, Ting Peng, Miaochun Xu, Shiyi Liu, Yashi Xu, Xiaojie Liu, Wencheng Ding, Li Li, Shitong Lin. Viral oncogenesis and immune remodeling: Decoding the therapeutic potential of immune checkpoint inhibitors in virus-associated cancers. Biomedicine & Pharmacotherapy 2025; 191 doi: 10.1016/j.biopha.2025.118515
|
| 42 |
Shahab Mahmoudvand, Somayeh Shokri, Mohsen Nakhaie, Farid Azizi Jalilian, Ameneh Mehri-Ghahfarrokhi, Reza Yarani, Ali Shojaeian. Small extracellular vesicles as key players in cancer development caused by human oncogenic viruses. Infectious Agents and Cancer 2022; 17(1) doi: 10.1186/s13027-022-00471-x
|
| 43 |
Teresa Catalano, Federico Selvaggi, Diana Liberata Esposito, Roberto Cotellese, Gitana Maria Aceto. Infectious Agents Induce Wnt/β-Catenin Pathway Deregulation in Primary Liver Cancers. Microorganisms 2023; 11(7) doi: 10.3390/microorganisms11071632
|
| 44 |
Ivana Milosevic, Nevena Todorovic, Ana Filipovic, Jelena Simic, Marko Markovic, Olja Stevanovic, Jovan Malinic, Natasa Katanic, Nikola Mitrovic, Natasa Nikolic. HCV and HCC Tango—Deciphering the Intricate Dance of Disease: A Review Article. International Journal of Molecular Sciences 2023; 24(22) doi: 10.3390/ijms242216048
|
| 45 |
Jili Wang, Shanshan Qu, Qinyan Xu, Zhaofeng Jin, Tian Li, Shuxian Zhang, Xihe Sun, Qingbin Cui. Correlation Analysis between Retention of Gd-DTPA in the Cystic Area of Brain Metastasis and MRI Signs. Journal of Oncology 2022; 2022 doi: 10.1155/2022/2738892
|
| 46 |
Jaime Sánchez-Meza, Marina Campos-Valdez, José Alfredo Domínguez-Rosales, Juliana Marisol Godínez-Rubí, Sarai Citlalic Rodríguez-Reyes, Erika Martínez-López, Guillermo M. Zúñiga-González, Laura Verónica Sánchez-Orozco. Chronic Administration of Diethylnitrosamine and 2-Acetylaminofluorene Induces Hepatocellular Carcinoma in Wistar Rats. International Journal of Molecular Sciences 2023; 24(9) doi: 10.3390/ijms24098387
|
| 47 |
Panagiotis Sarantis, Eleni-Myrto Trifylli, Evangelos Koustas, Kostas A. Papavassiliou, Michalis V. Karamouzis, Athanasios G. Papavassiliou. Immune Microenvironment and Immunotherapeutic Management in Virus-Associated Digestive System Tumors. International Journal of Molecular Sciences 2022; 23(21) doi: 10.3390/ijms232113612
|
| 48 |
Fei Feng, Yue Zhao. Hepatocellular Carcinoma: Prevention, Diagnosis, and Treatment. Medical Principles and Practice 2024; 33(5) doi: 10.1159/000539349
|
| 49 |
Effi Haque, M. Rezaul Karim, Aamir Salam Teeli, Magdalena Śmiech, Paweł Leszczynski, Dawid Winiarczyk, Emil D. Parvanov, Atanas G. Atanasov, Hiroaki Taniguchi. Molecular Mechanisms Underlying Hepatocellular Carcinoma Induction by Aberrant NRF2 Activation-Mediated Transcription Networks: Interaction of NRF2-KEAP1 Controls the Fate of Hepatocarcinogenesis. International Journal of Molecular Sciences 2020; 21(15) doi: 10.3390/ijms21155378
|
| 50 |
Huimin Yuan, Ruochen Xu, Senlin Li, Mengzhu Zheng, Qingyi Tong, Ming Xiang, Yonghui Zhang. The Malignant Transformation of Viral Hepatitis to Hepatocellular Carcinoma: Mechanisms and Interventions. MedComm 2025; 6(3) doi: 10.1002/mco2.70121
|
| 51 |
Mubarak A. Alamri. Bioinformatics and network pharmacology-based study to elucidate the multi-target pharmacological mechanism of the indigenous plants of Medina valley in treating HCV-related hepatocellular carcinoma. Saudi Pharmaceutical Journal 2023; 31(6) doi: 10.1016/j.jsps.2023.04.003
|
| 52 |
Hong Zhao, Yujie Wang, Yufeng Liu, Xiaohua Hao, Hongshan Wei, Wen Xie. The Effect of Protein FAM172A on Proliferation in HepG2 Cells and Investigation of the Possible Molecular Mechanism. Analytical Cellular Pathology 2019; 2019 doi: 10.1155/2019/5901083
|
| 53 |
Loraine Kay D. Cabral, Luca Grisetti, Muhammad Yogi Pratama, Claudio Tiribelli, Devis Pascut. Biomarkers for the Detection and Management of Hepatocellular Carcinoma in Patients Treated with Direct-Acting Antivirals. Cancers 2022; 14(11) doi: 10.3390/cancers14112700
|
| 54 |
Medi Kori, Kazim Yalcin Arga. Human oncogenic viruses: an overview of protein biomarkers in viral cancers and their potential use in clinics. Expert Review of Anticancer Therapy 2022; 22(11) doi: 10.1080/14737140.2022.2139681
|
| 55 |
Jenny Paola Alfaro-García, María Camila Granados-Alzate, Miguel Vicente-Manzanares, Juan Carlos Gallego-Gómez. An Integrated View of Virus-Triggered Cellular Plasticity Using Boolean Networks. Cells 2021; 10(11) doi: 10.3390/cells10112863
|
| 56 |
Decebal Fodor, Ioan Jung, Sabin Turdean, Catalin Satala, Simona Gurzu. Angiogenesis of hepatocellular carcinoma: An immunohistochemistry study. World Journal of Hepatology 2019; 11(3): 294-304 doi: 10.4254/wjh.v11.i3.294
|
| 57 |
Abbasi Majid, Jinxia Wang, Muhammad Nawaz, Sattar Abdul, Munawar Ayesha, Chunmei Guo, Qinglong Liu, Shuqing Liu, Ming-Zhong Sun. miR-124-3p Suppresses the Invasiveness and Metastasis of Hepatocarcinoma Cells via Targeting CRKL. Frontiers in Molecular Biosciences 2020; 7 doi: 10.3389/fmolb.2020.00223
|
| 58 |
Lu Zhao, Xiaojie Sun, Luhua Chen, Xiaoyan Feng, Xiqin Yang, Peng Zou, Xialu Wang, Rong Zhang. Hepatitis C Virus Core Protein Promotes the Metastasis of Human Hepatocytes by Activating the MAPK/ERK/PEA3-SRF/c-Fos/MMPs Axis. Archives of Medical Research 2022; 53(5) doi: 10.1016/j.arcmed.2022.06.004
|
| 59 |
Shahab Mahmoudvand, Somayeh Shokri, Azarakhsh Azaran, Seyed S. Seyedian, Manoochehr Makvandi, Habibollah Mirzaei, Sheida B. Sheikhrobat. Seronegative occult hepatitis C infection among hemodialysis patients: A prevalence study. Therapeutic Apheresis and Dialysis 2021; 25(2) doi: 10.1111/1744-9987.13535
|
| 60 |
Mechanisms and Therapy of Liver Cancer. Advances in Cancer Research 2021; 149 doi: 10.1016/bs.acr.2020.10.003
|
| 61 |
Daniel Sepulveda-Crespo, Salvador Resino, Isidoro Martinez. Strategies Targeting the Innate Immune Response for the Treatment of Hepatitis C Virus-Associated Liver Fibrosis. Drugs 2021; 81(4) doi: 10.1007/s40265-020-01458-x
|
| 62 |
Yantao Zhu, Junyi Liu, Lijuan Kang, Fangchao Ruan, Jianjian Li, Nian Zhang, Yanling Chen, Zhiying Yao, Haihua Yang, Jun Leng, Jinglin Wang, Jiali Wang. HCV Genotype Distribution and Molecular Characteristics of HCV Core Domain I in Persons Living with HIV and HCV from Yunnan Province, China. AIDS Research and Human Retroviruses 2026; 42(4) doi: 10.1177/08892229251405803
|
| 63 |
Pan Song, Zirui Gao, Yige Bao, Li Chen, Yuhe Huang, Yanyan Liu, Qiang Dong, Xiawei Wei. Wnt/β-catenin signaling pathway in carcinogenesis and cancer therapy. Journal of Hematology & Oncology 2024; 17(1) doi: 10.1186/s13045-024-01563-4
|
| 64 |
Gulsum Ozlem Elpek. Molecular pathways in viral hepatitis-associated liver carcinogenesis: An update. World Journal of Clinical Cases 2021; 9(19): 4890-4917 doi: 10.12998/wjcc.v9.i19.4890
|
| 65 |
K.T. Nachammai, R. Srinithi, P. Sangavi, R. Sangeetha, S. Gowtham Kumar, R. Lakshmi Sundaram, Kulanthaivel Langeswaran. Phospholipases in Physiology and Pathology. 2023; doi: 10.1016/B978-0-323-95697-0.00008-X
|
| 66 |
Teruhime Otoguro, Tomohisa Tanaka, Hirotake Kasai, Nobuhiro Kobayashi, Atsuya Yamashita, Takasuke Fukuhara, Akihide Ryo, Moto Fukai, Akinobu Taketomi, Yoshiharu Matsuura, Kohji Moriishi. Establishment of a Cell Culture Model Permissive for Infection by Hepatitis B and C Viruses. Hepatology Communications 2021; 5(4) doi: 10.1002/hep4.1653
|
| 67 |
Virginia Sedeño-Monge, Francisca Sosa-Jurado, Luis Márquez-Domínguez, Paulina Cortés-Hernández, Verónica Vallejo-Ruiz, Gerardo Santos-López. Pathogens Associated with the Development of Cancer in Humans. 2024; doi: 10.1007/978-3-031-62558-9_4
|
| 68 |
Malik Sallam, Roaa Khalil. Contemporary Insights into Hepatitis C Virus: A Comprehensive Review. Microorganisms 2024; 12(6) doi: 10.3390/microorganisms12061035
|
| 69 |
In-Woo Park, Hope K. Fiadjoe, Tamara Hoteit, Pankaj Chaudhary. Validation of signature molecular profiles of advanced HCV liver disease in hepatocellular carcinoma patients. Virus Research 2025; 357 doi: 10.1016/j.virusres.2025.199593
|
| 70 |
Hirotake Kasai, Atsuya Yamashita, Yasunori Akaike, Tomohisa Tanaka, Yoshiharu Matsuura, Kohji Moriishi, Marthandan Mahalingam, Swati Jain. HCV infection activates the proteasome via PA28γ acetylation and heptamerization to facilitate the degradation of RNF2, a catalytic component of polycomb repressive complex 1. mBio 2024; 15(11) doi: 10.1128/mbio.01691-24
|
| 71 |
Devis Pascut, Minh Hoang, Nhu N. Q. Nguyen, Muhammad Yogi Pratama, Claudio Tiribelli. HCV Proteins Modulate the Host Cell miRNA Expression Contributing to Hepatitis C Pathogenesis and Hepatocellular Carcinoma Development. Cancers 2021; 13(10) doi: 10.3390/cancers13102485
|
| 72 |
Gayatri Gouda, Manoj Kumar Gupta, Ravindra Donde, Lambodar Behera, Ramakrishna Vadde. Theranostics and Precision Medicine for the Management of Hepatocellular Carcinoma, Volume 2. 2022; doi: 10.1016/B978-0-323-98807-0.00003-X
|
| 73 |
Hong Jiang, Yi-fan Zhang, Ru-chao Zhang, Ya-nan Xing. Therapeutic, preventive, and pathogenetic advances in viral hepatitis. Frontiers in Cellular and Infection Microbiology 2026; 16 doi: 10.3389/fcimb.2026.1939337
|
| 74 |
Shehua Qian, Olga Golubnitschaja, Xianquan Zhan. Chronic inflammation: key player and biomarker-set to predict and prevent cancer development and progression based on individualized patient profiles. EPMA Journal 2019; 10(4) doi: 10.1007/s13167-019-00194-x
|
| 75 |
Ali Shojaeian, Mohsen Nakhaie, Zahra Sobhi Amjad, Armin Khaghani Boroujeni, Somayeh Shokri, Shahab Mahmoudvand. Leveraging metformin to combat hepatocellular carcinoma: its therapeutic promise against hepatitis viral infections. Journal of Cancer Metastasis and Treatment 2024; doi: 10.20517/2394-4722.2023.147
|
| 76 |
Savvina Moustafa, Katerina Kassela, Maria Bampali, Nikolas Dovrolis, Athanassios Kakkanas, Apostolos Beloukas, Penelope Mavromara, Ioannis Karakasiliotis. Hepatitis C Core Protein Induces a Genotype-Specific Susceptibility of Hepatocytes to TNF-Induced Death In Vitro and In Vivo. Viruses 2022; 14(11) doi: 10.3390/v14112521
|
| 77 |
Somayeh Shokri, Shahab Mahmoudvand, Reza Taherkhani, Fatemeh Farshadpour, Farid Azizi Jalalian. Complexity on modulation of NF‐κB pathways by hepatitis B and C: A double‐edged sword in hepatocarcinogenesis. Journal of Cellular Physiology 2019; 234(9) doi: 10.1002/jcp.28249
|